RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Compass Pathways Stock

Compass Pathways P/S 2025

Compass Pathways P/S

0

Ticker

CMPS

ISIN

US20451W1018

WKN

A2QCDR

As of Jul 14, 2025, Compass Pathways's P/S ratio stood at 0, a 0% change from the 0 P/S ratio recorded in the previous year.

The Compass Pathways P/S history

Compass Pathways Aktienanalyse

What does Compass Pathways do?

Compass Pathways PLC is a leading company specializing in the development of groundbreaking therapies for the treatment of mental illnesses. The company was founded in 2016 and is headquartered in London. Its goal is to revolutionize the treatment of depression and other mental illnesses. The business model of Compass Pathways is based on researching psychedelics as a potential treatment for patients suffering from severe depression and anxiety disorders. The company uses innovative approaches to precisely study the effects of psychedelics on the human brain and develop new therapy concepts and products from that. An important area of Compass Pathways is clinical research. The company collaborates closely with leading research institutions to understand the impacts of psychedelics on the human brain. The research results are then used to develop innovative methods for therapeutic use of psychedelics. Another important area of Compass Pathways is the development of therapeutic products. The company has developed a patented process for producing psilocybin, a substance found in hallucinogenic mushrooms. This process achieves a very high purity of the substance, enabling precise dosing and better control of its effects. The flagship product of Compass Pathways is COMP360, a medication based on psilocybin that is being developed for the treatment of depression. The medication is currently in clinical Phase 2 trials, showing promising results. If COMP360 receives approval, it has the potential to drastically change the way we treat depression. Compass Pathways is also active in other areas. The company conducts a range of research projects related to various psychedelic substances, including LSD and other hallucinogens. Another important area of Compass Pathways is training therapists and other professionals in the use of psychedelic substances. The company offers relevant courses to promote understanding of the therapeutic use of psychedelics and enable their safe and effective application for patient treatment. Overall, Compass Pathways is a company focused on the development of groundbreaking therapies for mental illnesses. Through combining cutting-edge research, innovative products, and professional education, the company has the potential to revolutionize the way we treat mental illnesses. Compass Pathways ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Compass Pathways's P/S Ratio

Compass Pathways's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Compass Pathways's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Compass Pathways's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Compass Pathways’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Compass Pathways stock

What is the price-to-earnings ratio of Compass Pathways?

The price-earnings ratio of Compass Pathways is currently 0.

How has the price-earnings ratio of Compass Pathways changed compared to last year?

The price-to-earnings ratio of Compass Pathways has increased by 0% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Compass Pathways high compared to other companies?

Yes, the price-to-earnings ratio of Compass Pathways is high compared to other companies.

How does an increase in the price-earnings ratio of Compass Pathways affect the company?

An increase in the price-earnings ratio of Compass Pathways would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Compass Pathways affect the company?

A decrease in the price-earnings ratio of Compass Pathways would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Compass Pathways?

Some factors that influence the price-earnings ratio of Compass Pathways are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Compass Pathways pay?

Over the past 12 months, Compass Pathways paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Compass Pathways is expected to pay a dividend of 0 USD.

What is the dividend yield of Compass Pathways?

The current dividend yield of Compass Pathways is .

When does Compass Pathways pay dividends?

Compass Pathways pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Compass Pathways?

Compass Pathways paid dividends every year for the past 0 years.

What is the dividend of Compass Pathways?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Compass Pathways located?

Compass Pathways is assigned to the 'Health' sector.

Wann musste ich die Aktien von Compass Pathways kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Compass Pathways from 7/14/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/14/2025.

When did Compass Pathways pay the last dividend?

The last dividend was paid out on 7/14/2025.

What was the dividend of Compass Pathways in the year 2024?

In the year 2024, Compass Pathways distributed 0 USD as dividends.

In which currency does Compass Pathways pay out the dividend?

The dividends of Compass Pathways are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Compass Pathways

Our stock analysis for Compass Pathways Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Compass Pathways Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.